Octave Specialty Group Net Debt Growth & History (OSG)
Octave Specialty Group's net debt was $59.0M for fiscal 2025.
View full Octave Specialty Group company overviewOctave Specialty Group annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $59.0M | −$83.0M | −58.45% |
| 2024 | 2024-12-31 | $141.9M | −$380.8M | −72.85% |
| 2023 | 2023-12-31 | $522.7M | −$135.0M | −20.52% |
| 2022 | 2022-12-31 | $657.7M | — | — |
| 2020 | 2020-12-31 | $2.75B | −$78.0M | −2.76% |
| 2019 | 2019-12-31 | $2.83B | −$54.0M | −1.87% |
| 2018 | 2018-12-31 | $2.88B | $2.51B | +683.53% |
| 2017 | 2017-12-31 | $367.7M | — | — |
| 2012 | 2012-12-31 | $106.3M | −$101.3M | −48.78% |
| 2011 | 2011-12-31 | $207.6M | $8.8M | +4.45% |
| 2010 | 2010-12-31 | $198.8M | — | — |
Octave Specialty Group quarterly net debt
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $76.4M | −$51.1M | −40.09% |
| Q1 2026 | 2026-03-31 | $23.5M | −$92.4M | −79.71% |
| Q4 2025 | 2025-12-31 | $59.0M | −$83.0M | −58.45% |
| Q3 2025 | 2025-09-30 | −$27.5M | −$652.7M | — |
| Q2 2025 | 2025-06-30 | $127.5M | −$373.0M | −74.53% |
| Q1 2025 | 2025-03-31 | $115.9M | −$382.3M | −76.73% |
| Q4 2024 | 2024-12-31 | $141.9M | −$380.8M | −72.85% |
| Q3 2024 | 2024-09-30 | $625.2M | $152.2M | +32.18% |
| Q2 2024 | 2024-06-30 | $500.4M | $32.4M | +6.93% |
| Q1 2024 | 2024-03-31 | $498.2M | $39.2M | +8.55% |
| Q4 2023 | 2023-12-31 | $522.7M | −$135.0M | −20.52% |
| Q3 2023 | 2023-09-30 | $473.0M | −$1.70B | −78.22% |
| Q2 2023 | 2023-06-30 | $468.0M | −$1.69B | −78.30% |
| Q1 2023 | 2023-03-31 | $459.0M | −$1.72B | −78.96% |
| Q4 2022 | 2022-12-31 | $657.7M | −$1.58B | −70.65% |
| Q3 2022 | 2022-09-30 | $2.17B | −$29.0M | −1.32% |
| Q2 2022 | 2022-06-30 | $2.16B | −$501.0M | −18.85% |
| Q1 2022 | 2022-03-31 | $2.18B | −$456.0M | −17.29% |
| As of Dec 31, 2021 | 2021-12-31 | $2.24B | −$508.0M | −18.48% |
| Q3 2021 | 2021-09-30 | $2.20B | −$499.0M | −18.48% |
| Q2 2021 | 2021-06-30 | $2.66B | −$74.0M | −2.71% |
| Q1 2021 | 2021-03-31 | $2.64B | −$64.0M | −2.37% |
| Q4 2020 | 2020-12-31 | $2.75B | −$78.0M | −2.76% |
| Q3 2020 | 2020-09-30 | $2.70B | −$232.5M | −7.93% |
| Q2 2020 | 2020-06-30 | $2.73B | −$226.3M | −7.65% |
| Q1 2020 | 2020-03-31 | $2.70B | −$218.8M | −7.49% |
| Q4 2019 | 2019-12-31 | $2.83B | −$54.0M | −1.87% |
| Q3 2019 | 2019-09-30 | $2.93B | — | — |
| Q2 2019 | 2019-06-30 | $2.96B | — | — |
| Q1 2019 | 2019-03-31 | $2.92B | — | — |
| Q4 2018 | 2018-12-31 | $2.88B | $2.51B | +684.98% |
| Q4 2017 | 2017-12-31 | $367.0M | — | — |
| Q3 2014 | 2014-09-30 | $1.18B | — | — |
| Q2 2014 | 2014-06-30 | $907.0M | — | — |
| Q1 2014 | 2014-03-31 | $940.4M | $839.7M | +833.56% |
| Q3 2016 · Dec 31 | 2013-12-31 | $885.8M | $779.5M | +733.05% |
| Q1 2013 | 2013-03-31 | $100.7M | −$86.5M | −46.20% |
| Q4 2012 | 2012-12-31 | $106.3M | −$101.3M | −48.78% |
| Q3 2012 | 2012-09-30 | $56.8M | −$142.3M | −71.45% |
| Q2 2012 | 2012-06-30 | $95.0M | −$104.9M | −52.48% |
| Q1 2012 | 2012-03-31 | $187.3M | — | — |
| Q4 2011 | 2011-12-31 | $207.6M | $8.8M | +4.45% |
| Q3 2011 | 2011-09-30 | $199.1M | — | — |
| Q2 2011 | 2011-06-30 | $200.0M | — | — |
| Q4 2010 | 2010-12-31 | $198.8M | — | — |
Octave Specialty Group net debt trends
Over the last five fiscal years, Octave Specialty Group's net debt decreased from $2.75B to $59.0M, a change of −$2.69B. The latest reported quarter, Q2 2026, shows $76.4M.
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Octave Specialty Group source filings ↗